Kanya Rajangam - Mar 10, 2025 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Role
Pres. & Chief Med. & Dev. Off.
Signature
/s/ Robert Cutler, attorney-in-fact
Stock symbol
SNTI
Transactions as of
Mar 10, 2025
Transactions value $
$0
Form type
4
Date filed
3/11/2025, 04:23 PM
Previous filing
Mar 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNTI Common Stock Conversion of derivative security $74.3K +33K $2.25 33K Mar 10, 2025 Iyer Family Revocable Trust dated Aug 26 2012 F1
holding SNTI Common Stock 87K Mar 10, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNTI Series A Convertible Preferred Stock Conversion of derivative security -$74.3K -33 -100% $2,250.00 0 Mar 10, 2025 Common Stock 33K $2.25 Iyer Family Revocable Trust dated Aug 26 2012 F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person and her spouse are trustees of the Iyer Family Revocable Trust dated Aug 26 2012. Each of the reporting person and her spouse have voting and dispositive power over the Series A Preferred Stock, Common Stock and Warrants. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F2 The shares of Series A Convertible Preferred Stock have no expiration date.